Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | LM-364 |
| Trade Name | |
| Synonyms | LM364|LM 364 |
| Drug Descriptions |
LM-364 is an antibody-drug conjugate (ADC) comprising an ANP-dependent antibody targeting NECTIN4 linked to a topoisomerase I inhibitor, which potentially inhibits growth of Nectin4-expressing tumors (Cancer Res (2026) 86 (7_Supplement): 4433). |
| DrugClasses | NECTIN4 Antibody 14 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| LM-364 | LM-364 | 0 | 1 |
| LM-364 + Tislelizumab | LM-364 Tislelizumab | 0 | 1 |